Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PDSB
#3621
PDS Biotechnology Corporation Common Stock
0.6
8
-1.45%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-1.45%
Monthly Change
-32.00%
6 month change
-47.29%
Year Change
-52.45%
Previous Close
0.6
9
Open
0.6
8
Bid
Ask
Low
0.6
8
High
0.6
8
Volume
6
Markets
US Stock Market
Healthcare
PDSB
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
22.26 M
28.45 M
30.72 M
36.68 M
45.4 M
—
Valuation ratios
Enterprise value
18.8 M
165.23 M
252.48 M
132.3 M
32.3 M
100.08 M
Price to earnings ratio
—
-12.27
-7.43
-3.71
-1.58
-5.53
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
-16.61
-11.81
-4.74
-1.7
-5.85
Price to book ratio
—
3.28
6.9
6.1
3.13
4.88
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.48
-0.25
-0.53
-0.72
-0.83
-0.85
Return on equity %
0.55
-0.27
-0.93
-1.64
-1.98
-2.34
Return on invested capital %
9 999.18
-16.09 K
-23.94 K
-6 611.39
-1 706.76
-966.63
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
9.28
17.8
7.79
4.33
2.64
9.97
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
0.3
0.33
0.2
1
Long term debt to total equity ratio
—
—
0.52
0.75
0.48
2.84
Per share metrics
Operating cash flow per share
—
-0.49
-0.9
-1.09
-0.96
-0.77
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
2.55
2.58
1.83
1.14
3.39
Net current asset value per share
—
2.61
2.67
1.91
1.24
3.61
Tangible book value per share
—
2.47
1.54
0.84
0.52
1.62
Working capital per share
—
2.46
2.33
1.47
0.77
2.16
Book value per share
—
2.47
1.54
0.84
0.52
1.62
News
PDS Biotech amends Phase 3 trial to add accelerated approval path
PDS Biotech reports 9.6-month progression-free survival in prostate cancer study
PDS Biotech secures patent for cancer immunotherapy PDS0101
PDS Biotech stock soars after FDA meeting provides accelerated approval path
PDS Biotech submits amended protocol for phase 3 cancer trial
PDS Biotech secures new patent for cancer immunotherapy in Japan
PDS Biotechnology (PDSB) Upgraded to Buy: Here's Why
PDS Biotech secures FDA meeting to discuss accelerated approval pathway
PDS Biotechnology Corporation (PDSB) Q3 2025 Earnings Call Transcript
PDS Biotech raises $5.3 million in registered direct offering
PDS Biotechnology stock falls after $5.3 million registered direct offering
PDS Biotech reports positive data on cancer immunotherapy mechanisms